According to the latest report published by Data Bridge Market Research, the Gel Stent Market

• The global gel stent market size was valued at USD 1.60 billion in 2025 and is expected to reach USD 2.57 billion by 2033, at a CAGR of 6.14% during the forecast period.

DBMR team is focused on understanding client’s business and their needs so that the finest Gel Stent Market research report is delivered to the client for a potential growth and success. All the parameters are systematically studied by the experts for offering the best solution to the clients. Request an analyst call or drop down an enquiry to get detailed market report. The report is very helpful for both established business and emerging market player in the industry as it provides profound market insights. The Gel Stent Market document endows with the plentiful insights and business solutions that will help attain the new horizons of success.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-gel-stent-market

Gel Stent Market Segmentation and Market Companies

Segments

- By Type: Biodegradable Stents, Non-Biodegradable Stents
- By Application: Glaucoma Surgery, Cataract Surgery, Others
- By End User: Hospitals, Ophthalmic Clinics, Others

The global gel stent market is segmented based on type, application, and end user. In terms of type, the market is categorized into biodegradable stents and non-biodegradable stents. Biodegradable stents are designed to dissolve over time and are preferred for certain medical conditions. Non-biodegradable stents, on the other hand, offer long-lasting support. In the application segment, the market is divided into glaucoma surgery, cataract surgery, and others. Gel stents are commonly used in glaucoma surgery to improve the flow of fluid in the eye. Cataract surgery also utilizes gel stents for effective treatment. Based on end user, the market is segmented into hospitals, ophthalmic clinics, and others, where hospitals are the major contributors due to the high volume of surgeries performed.

Market Players

- Allergan
- Santen Pharmaceutical Co., Ltd.
- Bausch & Lomb Incorporated
- Glaukos Corporation
- Ivantis, Inc.
- MicroOptx
- Neomedix Corporation
- PRESERFLO MicroShunt
- InjectSense
- CORNeus

Key players in the global gel stent market include Allergan, Santen Pharmaceutical Co., Ltd., Bausch & Lomb Incorporated, Glaukos Corporation, Ivantis, Inc., MicroOptx, Neomedix Corporation, PRESERFLO MicroShunt, InjectSense, and CORNeus. These companies are at the forefront of developing innovative gel stent technologies and expanding their product portfolios to cater to the growing demand for minimally invasive surgical solutions in ophthalmology. Strategic collaborations, product launches, and acquisitions are some of the key strategies adopted by these market players to gain a competitive edge in the global gel stent market.

The global gel stent market is witnessing significant growth, driven by factors such as an increasing prevalence of ophthalmic disorders, technological advancements in surgical procedures, and a rising preference for minimally invasive treatments. Biodegradable stents are gaining traction due to their ability to dissolve over time, reducing the risk of complications associated with non-biodegradable stents. Glaucoma surgery and cataract surgery are key applications driving the demand for gel stents, with these procedures being common ophthalmic surgeries globally. Gel stents play a crucial role in improving the outcomes of these surgeries by maintaining intraocular pressure and enhancing fluid drainage.

Key market players such as Allergan, Glaukos Corporation, and Bausch & Lomb are focusing on research and development initiatives to introduce advanced gel stent technologies with improved efficacy and safety profiles. Collaborations with healthcare providers and research institutions are also helping these companies expand their market presence and develop innovative solutions tailored to meet the specific needs of ophthalmic surgeons and patients. The competitive landscape of the gel stent market is characterized by intense R&D activities, product launches, and strategic partnerships aimed at enhancing product offerings and gaining a competitive advantage.

The adoption of gel stents is expected to increase further as healthcare facilities strive to offer advanced ophthalmic treatments that ensure better patient outcomes and shorter recovery times. With a growing geriatric population globally and a rising incidence of eye-related ailments, the demand for gel stents is projected to surge in the coming years. Moreover, the shift towards outpatient ophthalmic procedures and the emphasis on cost-effective treatment options are driving the adoption of gel stents in various healthcare settings. Market players are also focusing on expanding their distribution networks to reach a broader customer base and strengthen their market position.

Technological innovations such as biocompatible materials, advanced drug-eluting properties, and customizable design features are expected to drive the evolution of gel stent technologies in the foreseeable future. These advancements will not only enhance the safety and efficacy of gel stents but also open up new avenues for applications in the field of ophthalmology. As regulatory bodies worldwide continue to scrutinize medical devices for their safety and performance, market players are investing in compliance measures to ensure that their gel stents meet the necessary quality standards and regulatory requirements, further boosting consumer confidence and market penetration.

In conclusion, the global gel stent market is poised for significant growth, driven by technological advancements, increasing prevalence of ophthalmic disorders, and a growing demand for minimally invasive surgical solutions. Key market players are focusing on innovation, strategic collaborations, and expansion strategies to capitalize on emerging opportunities and address the evolving needs of healthcare providers and patients. With a positive outlook for the market, the adoption of gel stents is likely to witness a steady rise, transforming the landscape of ophthalmic surgeries and enhancing patient care outcomes worldwide.The global gel stent market is experiencing a transformative phase driven by technological advancements and the increasing prevalence of ophthalmic disorders. With key players like Allergan, Glaukos Corporation, and Bausch & Lomb leading the way, the market is witnessing a surge in research and development activities aimed at introducing more effective and safer gel stent technologies. By focusing on collaborations with healthcare providers and research institutions, these market players are expanding their product portfolios and enhancing their market presence to cater to the specific needs of ophthalmic surgeons and patients.

The demand for gel stents is expected to escalate further as healthcare facilities strive to offer advanced ophthalmic treatments that ensure improved patient outcomes and shorter recovery times. The aging global population and the increasing incidence of eye-related ailments are also contributing to the growing adoption of gel stents in various healthcare settings. Additionally, the trend towards outpatient ophthalmic procedures and the emphasis on cost-effective treatment options are propelling the utilization of gel stents across different market segments.

Technological innovations such as the use of biocompatible materials, advanced drug-eluting properties, and customizable design features are anticipated to drive the evolution of gel stent technologies in the foreseeable future. These advancements not only enhance the safety and efficacy of gel stents but also present new opportunities for applications in the field of ophthalmology. Market players are proactively investing in compliance measures to ensure that their gel stents adhere to stringent quality standards and regulatory requirements, thereby enhancing consumer confidence and market penetration.

In conclusion, the global gel stent market is poised for substantial growth as a result of ongoing advancements, increasing disease prevalence, and the rising demand for minimally invasive surgical solutions. Key market players are strategically positioning themselves to capitalize on emerging opportunities and address the evolving needs of the healthcare industry. As the adoption of gel stents continues to rise steadily, the landscape of ophthalmic surgeries is expected to undergo significant transformation, ultimately enhancing patient care outcomes on a global scale.

Frequently Asked Questions About This Report

Which product type is expected to witness the fastest growth through 2033?
How is the Gel Stent Market segmented by end-use industry?
How is Greenwashing risk managed in the Gel Stent Market industry?
How is Brand Perception changing in the Gel Stent Market?
What are the trade barriers affecting the Gel Stent Market in Region?
What is the role of automation in Gel Stent Market production/delivery?
What is the impact of the Right to Repair on Gel Stent Market ESG scores?
What are the feedback loops used by Gel Stent Market leaders?
How is the rising prevalence of Industry Need driving Gel Stent Market demand?
What are the major challenges the Gel Stent Market currently faces?
Which application segment generated the most revenue in 2025?

Browse More Reports:

Global Beneficial Insects Market
Global Soups Market
Europe Powder Coatings Market
Global Nanoencapsulation Market
Europe Advanced Wound Care Dressings Market
Global Managed Security Services Market
Global Wooden Packaging Market
Global Hanta Virus Market
Global Password Based Authentication Market
Global Brain Monitoring Devices Market
Global Phosphorus Trichloride Market
Global Private 6G Market
Global Medical Drones Market
Nigeria Modified starch Market
Global Poultry Keeping Machinery Market

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 1024
Email:- corporatesales@databridgemarketresearch.com